Literature DB >> 15132884

Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights.

Gül Bahtiyar1, John J Shin, Ayse Aytaman, James R Sowers, Samy I McFarlane.   

Abstract

Up to one third of patients with chronic hepatitis C virus (HCV) develop type 2 diabetes mellitus (DM). This prevalence is much higher than that observed in the general population, and in patients with other chronic liver diseases such as hepatitis B virus, alcoholic liver disease, and primary biliary cirrhosis. Further, HCV seropositivity in patients with DM appears to be higher than in the general population. Post- liver transplantation DM also appears to be higher among patients with HCV. In this article, we review the epidemiologic association between HCV and DM, highlighting the most recent pathophysiologic insights into the mechanisms underlying this association.

Entities:  

Mesh:

Year:  2004        PMID: 15132884     DOI: 10.1007/s11892-004-0023-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  41 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  The continuing increase of diabetes in the US.

Authors:  A H Mokdad; E S Ford; B A Bowman; D E Nelson; M M Engelgau; F Vinicor; J S Marks
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

3.  High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study.

Authors:  S Grimbert; P Valensi; C Lévy-Marchal; G Perret; J P Richardet; C Raffoux; J C Trinchet; M Beaugrand
Journal:  Gastroenterol Clin Biol       Date:  1996

4.  Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.

Authors:  S Caronia; K Taylor; L Pagliaro; C Carr; U Palazzo; J Petrik; S O'Rahilly; S Shore; B D Tom; G J Alexander
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

5.  [Relationship between iron stores and diabetes mellitus in patients infected by hepatitis C virus: a case-control study].

Authors:  C Hernández; J Genescà; J Ignasi Esteban; L García; R Simó
Journal:  Med Clin (Barc)       Date:  2000-06-03       Impact factor: 1.725

6.  Iron overload in patients with chronic viral hepatitis: how common is it?

Authors:  O Riggio; F Montagnese; P Fiore; S Folino; S Giambartolomei; C Gandin; M Merli; I Quinti; N Violante; S Caroli; O Senofonte; L Capocaccia
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

7.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

8.  Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.

Authors:  A S Petrides; T Stanley; D E Matthews; C Vogt; A J Bush; H Lambeth
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

9.  Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy.

Authors:  M G Saleh; C J Tibbs; J Koskinas; L M Pereira; A B Bomford; B C Portmann; I G McFarlane; R Williams
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

10.  Effect of interferon on glucose tolerance and insulin sensitivity.

Authors:  V A Koivisto; R Pelkonen; K Cantell
Journal:  Diabetes       Date:  1989-05       Impact factor: 9.461

View more
  16 in total

Review 1.  Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment.

Authors:  Jessica L Hwang; Roy E Weiss
Journal:  Diabetes Metab Res Rev       Date:  2014-02       Impact factor: 4.876

Review 2.  Post-transplant diabetes mellitus: risk reduction strategies in the elderly.

Authors:  Alain Duclos; Lawrence M Flechner; Charles Faiman; Stuart M Flechner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis.

Authors:  Takahisa Nakamura; Masato Furuhashi; Ping Li; Haiming Cao; Gurol Tuncman; Nahum Sonenberg; Cem Z Gorgun; Gökhan S Hotamisligil
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

Review 4.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 5.  Extrahepatic manifestations of hepatitis C infection: navigating CHASM.

Authors:  Amy C Sherman; Kenneth E Sherman
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

6.  Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance.

Authors:  Hong Joo Kim; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

Review 7.  Targeting host factors: a novel rationale for the management of hepatitis C virus.

Authors:  Mahmoud Aboelneen Khattab
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

8.  HIV infection and glycemic response to newly initiated diabetic medical therapy.

Authors:  Jennifer H Han; Heidi M Crane; Scarlett L Bellamy; Ian Frank; Serena Cardillo; Gregory P Bisson
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

9.  Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats.

Authors:  Bai Xue; Siddharth Sukumaran; Jing Nie; William J Jusko; Debra C Dubois; Richard R Almon
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

10.  Peroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistance.

Authors:  Francesco Negro
Journal:  PPAR Res       Date:  2009-01-06       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.